ArticleJAMA network open2023

Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19.

Alberto Mateo-Urdiales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.